205 related articles for article (PubMed ID: 19502791)
1. Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells.
Wharry CE; Haines KM; Carroll RG; May MJ
Cancer Biol Ther; 2009 Aug; 8(16):1567-76. PubMed ID: 19502791
[TBL] [Abstract][Full Text] [Related]
2. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
[TBL] [Abstract][Full Text] [Related]
3. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical NFκB activation promotes chemokine expression in podocytes.
Valiño-Rivas L; Gonzalez-Lafuente L; Sanz AB; Ruiz-Ortega M; Ortiz A; Sanchez-Niño MD
Sci Rep; 2016 Jun; 6():28857. PubMed ID: 27353019
[TBL] [Abstract][Full Text] [Related]
5. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
[TBL] [Abstract][Full Text] [Related]
6. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
Front Immunol; 2019; 10():997. PubMed ID: 31134075
[TBL] [Abstract][Full Text] [Related]
7. IL-1β stimulates a novel, IKKα -dependent, NIK -independent activation of non-canonical NFκB signalling.
McIntosh K; Khalaf YH; Craig R; West C; McCulloch A; Waghmare A; Lawson C; Chan EYW; Mackay S; Paul A; Plevin R
Cell Signal; 2023 Jul; 107():110684. PubMed ID: 37080443
[TBL] [Abstract][Full Text] [Related]
8. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
9. TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21.
Sanz AB; Sanchez-Niño MD; Izquierdo MC; Jakubowski A; Justo P; Blanco-Colio LM; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
PLoS One; 2010 Jan; 5(1):e8955. PubMed ID: 20126461
[TBL] [Abstract][Full Text] [Related]
10. NIK is involved in constitutive activation of the alternative NF-kappaB pathway and proliferation of pancreatic cancer cells.
Nishina T; Yamaguchi N; Gohda J; Semba K; Inoue J
Biochem Biophys Res Commun; 2009 Oct; 388(1):96-101. PubMed ID: 19646419
[TBL] [Abstract][Full Text] [Related]
11. Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells.
Matos P; Jordan P
J Biol Chem; 2006 May; 281(19):13724-13732. PubMed ID: 16551621
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
13. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
Yilmaz ZB; Weih DS; Sivakumar V; Weih F
EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
15. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
Lu S; He T; Zhang Y; Zhou B; Zhang Q; Yan S
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326109
[TBL] [Abstract][Full Text] [Related]
16. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.
de Jong SJ; Albrecht JC; Schmidt M; Müller-Fleckenstein I; Biesinger B
J Biol Chem; 2010 May; 285(22):16495-503. PubMed ID: 20353939
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.
Singh MK; Singh L; Chosdol K; Pushker N; Saini N; Meel R; Bakhshi S; Sen S; Kashyap S
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2969-2982. PubMed ID: 31612319
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.
Tapia MA; González-Navarrete I; Dalmases A; Bosch M; Rodriguez-Fanjul V; Rolfe M; Ross JS; Mezquita J; Mezquita C; Bachs O; Gascón P; Rojo F; Perona R; Rovira A; Albanell J
Cell Cycle; 2007 Sep; 6(18):2284-92. PubMed ID: 17890907
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
20. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S
EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
